KF 19514

Drug Profile

KF 19514

Alternative Names: KF19514

Latest Information Update: 16 Oct 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kyowa Hakko
  • Class Antiasthmatics; Naphthyridines; Small molecules
  • Mechanism of Action Type 1 cyclic nucleotide phosphodiesterase inhibitors; Type 4 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Allergic rhinitis; Asthma

Most Recent Events

  • 16 Oct 2006 Discontinued - Preclinical for Allergic rhinitis in Japan (PO)
  • 16 Oct 2006 Discontinued - Preclinical for Asthma in Japan (PO)
  • 09 Nov 1999 Preclinical development for Allergic rhinitis in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top